8 drug(s) with this reaction
8,553 total reports
Abdominal Pain Upper has been reported as an adverse reaction across 8 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,553 adverse event reports mention abdominal pain upper in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with abdominal pain upper, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have abdominal pain upper listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal pain upper, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
8 drug(s) manufactured by Amgen Inc have abdominal pain upper listed in their FDA adverse event reports: APREMILAST, DENOSUMAB, ERENUMAB-AOOE, CINACALCET HYDROCHLORIDE, PEGFILGRASTIM, and others.
There are a combined 8,553 reports of abdominal pain upper across 8 Amgen Inc drug(s) in the FDA adverse event database.